Advertisement
SC bars Glenmark from selling copies of Merck diabetes drugs: Sources

SC bars Glenmark from selling copies of Merck diabetes drugs: Sources

The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

Zeba Siddiqui and Nivedita Bhattacharjee
  • Mumbai,
  • Updated May 15, 2015 5:47 PM IST
SC bars Glenmark from selling copies of Merck diabetes drugs: SourcesThe court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

The Supreme Court has blocked Glenmark Pharmaceuticals Ltd (GLEN.NS) from selling copies of US drugmaker Merck & Co Inc's (MRK.N) diabetes drugs Januvia and Janumet, sources with knowledge of the matter said after a court hearing on Friday.

The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

Advertisement

Related Articles

Merck sued Glenmark in 2013 for infringing a patent it has on sitagliptin, the chemical compound in Januvia and Janumet. Glenmark sells the medicines under the brand names Zita and Zita-met.

(Reuters)

 

Published on: May 15, 2015 5:18 PM IST
    Post a comment0